Inflammatory myopathy and severe rhabdomyolysis induced by leuprolide acetate therapy for prostate cancer: a case report
<p>Abstract</p> <p>Introduction</p> <p>Leuprolide acetate is a synthetic analog of gonadotropin-releasing hormone used for the treatment of prostate cancer. Its side effects are hot flashes, nausea, and fatigue. We report a case of a patient with proximal inflammatory m...
Main Authors: | Rohacek Martin, Bergner Michael, Erne Paul |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-08-01
|
Series: | Journal of Medical Case Reports |
Online Access: | http://www.jmedicalcasereports.com/content/5/1/409 |
Similar Items
-
Effects of leuprolide acetate on the quality of life of patients with prostate cancer: A prospective longitudinal cohort study
by: Myung Soo Kim, et al.
Published: (2021-09-01) -
Leuprolide acetate induces structural and functional recovery of injured spinal cord in rats
by: Carmen Díaz-Galindo, et al.
Published: (2015-01-01) -
Effectiveness, Safety and Obedience of Dienogest and Leuprolide Acetate in Postlaparoscopic Endometriosis Patients
by: Joko P. Purwanto, et al.
Published: (2020-01-01) -
Pharmacoeconomic analysis of leuprolide acetate (Eligard) 45 mg once in 6 months for advanced prostate cancer in Russian Federation
by: M. Yu. Frolov, et al.
Published: (2015-12-01) -
Pharmacokinetic and pharmacodynamic comparison of subcutaneous intramuscular leuprolide acetate formulations in male subjects
by: Daniel Saltzstein, et al.
Published: (2018-02-01)